ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metabolomics in the study of kidney diseases

Weiss, Robert H.*; Kim, Kyoungmi
NATURE REVIEWS NEPHROLOGY2012-1DOI: 10.1038/nrneph.2011.152
211被引5阅读
引用收藏
分享

摘要

Metabolomics-the nontargeted measurement of all metabolites produced by the body-is beginning to show promise in both biomarker discovery and, in the form of pharmacometabolomics, in aiding the choice of therapy for patients with specific diseases. In its two basic forms (pattern recognition and metabolite identification), this developing field has been used to discover potential biomarkers in several renal diseases, including acute kidney injury (attributable to a variety of causes), autosomal dominant polycystic kidney disease and kidney cancer. NMR and gas chromatography or liquid chromatography, together with mass spectrometry, are generally used to separate and identify metabolites. Many hurdles need to be overcome in this field, such as achieving consistency in collection of biofluid samples, controlling for batch effects during the analysis and applying the most appropriate statistical analysis to extract the maximum amount of biological information from the data obtained. Pathway and network analyses have both been applied to metabolomic analysis, which vastly extends its clinical relevance and effects. In addition, pharmacometabolomics analyses, in which a metabolomic signature can be associated with a given therapeutic effect, are beginning to appear in the literature, which will lead to personalized therapies. Thus, metabolomics holds promise for early diagnosis, increased choice of therapy and the identification of new metabolic pathways that could potentially be targeted in kidney disease.

学科与关键词

关键词
NMR ISOTOPOMER ANALYSISMASS-SPECTROMETRYHUMAN URINEINSULIN-RESISTANCEFANCONIS-SYNDROMEPATHWAY ANALYSISSYSTEMS BIOLOGYINBORN-ERRORSAMINO-ACIDSCANCER
相关
加载中…
  • Metabolomics in Adult and Pediatric Nephrology
    Fanos, Vassilios*; Fanni, Claudia; Ottonello, Giovanni; Noto, Antonio; Dessi, Angelica; Mussap, MicheleMOLECULES, 2013, 18(5): 4844-4857.被引 23
  • Proteomic biomarkers in kidney disease: issues in development and implementation
    Mischak, Harald; Delles, Christian; Vlahou, Antonia; Vanholder, Raymond*NATURE REVIEWS NEPHROLOGY, 2015, 11(4): 221-232.被引 95
  • Metabolomics toward personalized medicine
    Jacob, Minnie; Lopata, Andreas L.; Dasouki, Majed; Rahman, Anas M. Abdel*Mass Spectrometry Reviews, 2019, 38(3): 221-238.被引 236
查看全部 →

发表信息

论文状态
公开发表
期刊
NATURE REVIEWS NEPHROLOGY
发表日期
2012-01
卷期
第 8 卷, 第 1 期
页码
22-33
DOI
10.1038/nrneph.2011.152
语言
English
成果收录
SCIE
资助标注
NIH (Early Detection Research Network) [5UO1CA86402]; NIH [1R01CA135401-01A1, 1R01DK082690-01A1]; Medical Service of the US Department of Veterans' Affairs

作者

  • W

    Weiss, Robert H. (通讯) (第一作者)

  • K

    Kim, Kyoungmi

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417